🔎 Trials Near Me

Gara Jalqabaatti › Baayyee Ulfaataa › Texas › Amarillo

Qorannoo klinikaalii Baayyee Ulfaataa Amarillo, TX keessatti

Qorannoo 7 Baayyee Ulfaataa f Amarillo fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • PharmaTex Research, LLC, Amarillo
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Namoota walitti qabaa jiraSadarkaa 2
  • Amarillo Medical Specialists /ID# 282380, Amarillo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Namoota walitti qabaa jiraSadarkaa 3
  • Amarillo Med Spec LLP, Amarillo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07668414

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Namoota walitti qabaa jiraSadarkaa 3
  • Amarillo Medical Specialists, Amarillo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07720271

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, Amarillo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, Amarillo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284875

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Namoota walitti qabaa jiraSadarkaa 1
  • Amarillo Medical Specialists, Amarillo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT07607587

Qorannoo Baayyee Ulfaataa magaalota biroo keessatti

Qorannoo biroo Amarillo keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.